[1] Karras A. Lupus nephritis:up-to-date[J]. Rev MedInterne, 2015, 36(2):98-106. [2] Parikh SV, Alvarado A, Malvar A, et al. The kidney biopsy in lupus nephritis:past, present, and future[J].Semin Nephrol,2015, 35(5):465-477. [3] Tang X, Huang Y, Deng W, et al. Clinical and serologic correlations and autoantibody clusters in systemic lupus erythematosus:a retrospective review of 917 patients in South China[J]. Medicine(Baltimore), 2010, 89(1):62-67. [4] Jain D,Aggarwal HK,Kaverappa V,et al.Anti-dsDNA negativeand anti-Ro positive lupus nephritis:a report of a rare case[J].Reumatismo,2014,65(6):302-306. [5] Tan Y, Song D, Wu LH, et al. Serum levels and renal depositionof C1q complement component and its antibodies reflectdisease activity of lupus nephritis[J]. BMC Nephrol, 2013, 14(1):63. [6] Franchin G, Son M, Kim SJ, et al. Anti-DNA antibodies cross-react with C1q[J]. J Autoimmun, 2013, 44:34-39. [7] Tunnicliffe DJ, Singh-Grewal D, Kim S, et al. Diagnosis, monitoring, and treatment of systemic lupus erythematosus:a systematic review of clinical practice guidelines[J]. Arthritis Care Res(Hoboken), 2015, 67(10):1440-1452. [8] Ntatsaki E, Isenberg D. Risk factors for renal disease in systemic lupus erythematosus and their clinical implications[J]. Expert Rev Clin Immunol, 2015, 11(7):837-848. [9] Davidson A. What is damaging the kidney in lupus nephritis?[J]. Nat Rev Rheumatol, 2016, 12(3):143-153. [10] Crispin JC,Liossis SN,Kis-Toth K,et al.Pathogenesis of human systemic lupus erythematosus:recent advances[J].Trends Mol Med,2010,16(2):47-57. [11] Katsumata Y, Miyake K, Kawaguchi Y, et al. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis:a controlled study of 126 consecutive patients.[J].Arthritis Rheum,2011,63(8):2436-2444. [12] Sui M,Lin Q,Xu Z,et al.Simultaneous positivity for anti-DNA,anti-nucleosome and anti-histone antibodies is a marker for more severe lupus nephritis[J].J Clin Immunol,2013,33(2):378-387. [13] ZivkovicV, Stankovic A, Cvetkovic T, et al. Anti-dsDNA, Anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus[J]. Srp Arh Celok Lek, 2014, 142(7/8):431-436. [14] Trad B,Ben Hassine H,Khalifa M,et al.Anti-Clq antibodies and systemic lupus erythematosus in the Tunisian population[J].Pathol Biol,2013,61(3):113-116. [15] Ballanti E,Perricone C,Greco E,et al.Complement and autoimmunity[J]. Immunol Res,2013,56(2/3):477-491. [16] Li Y,Fang X,Li QZ.Biomarker profiling for lupus nephritis[J].Genomics Proteomics Bioinformatics,2013,11(3):158-165. [17] Yang XW, Tan Y, Yu F, et al. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis[J]. Nephrol Dial Transplant, 2012, 27(9):3552-3559. [18] 张晓慧,张卓莉.C反应蛋白与系统性红斑狼疮的相关性[J].中华临床免疫和变态反应杂志,2014,8(1):45-51. [19] 刘东伟,刘章锁.狼疮性肾炎诱导治疗的变迁[J].中国实用内科杂志,2015,35(6):471-474. |